Update From the NHLBI: Lung Vascular and Pulmonary Hypertension Research

Advances in Pulmonary Hypertension

关键词: Cardiology;    Pediatrics;    Psychosocial Issues;    Lifestyle Issues;    Social Work;    WHO Group 1- Pulmonary Arterial Hypertension;    Research;    early childhood;    Social Security Disability;    nitric oxide;    endothelial dysfunction;    Education;    Classification;    Epidemiology;   

DOI  :  

学科分类：医学（综合）

来源: Pulmonary Hypertension Association

【 摘 要 】

The National Institutes of Health (NIH), a part of the US Department of Health and Human Services, is the nation’s biomedical research agency. The NIH is the largest source of funding for biomedical research in the world, funding thousands of scientists in universities and research institutions. The NIH’s mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability. The NIH is composed of 27 institutes and centers, each with a specific mission, often focusing on particular diseases or body systems. The National Heart, Lung, and Blood Institute (NHLBI) is one of the component institutes, whose mission is to provide global leadership for research, training, and education programs that promote the prevention and treatment of heart, lung, and blood diseases. The Division of Lung Diseases (DLD) within the NHLBI is responsible for administration of the extramural grant and contract portfolio in lung diseases research, which includes diseases of the airways, lung tissues, including the interstitial compartments and cells, the lung vascular systems, and sleep. Additional information about the NIH and its mission, its collective institutes and centers, and the DLD can be found by accessing the following Web site and its associated links: http://www.nih.gov/index.html.

【 授权许可】

All Rights reserved